Ophthalmic Solutions

Medications that provide the best solution for your patients.

All Epicur ophthalmic solutions are manufactured to FDA standards and practices to ensure the same quality is in every batch, every time you order. Below is our current list of ophthalmic solutions that Epicur Pharma formulates in our 503B facility. Be sure to request Epicur products to get true quality that is backed by FDA oversight.

  • Chloramphenicol 1% Ophthalmic Solution, 10 mL
  • Cidofovir 0.5% Ophthalmic Solution, 5 mL
  • Cyclosporin AQ 1% and 2% Ophthalmic Suspension, 10 mL
  • Cyclosporin Coconut Oil 1% and 2% Ophthalmic Solution, 15 mL
  • Cyclosporin Corn Oil 1% and 2% Ophthalmic Solution, 10 mL
  • Cyclosporin Olive Oil 2% Ophthalmic Solution, 10 mL
  • Cyclosporin/Tacrolimus MCT Oil 2/0.02% and 2/0.03% Ophthalmic Solution, 10 mL
  • Demecarium Bromide 0.125% and 0.25% Ophthalmic Solution, 10 mL
  • EDTA 1% and 2% Ophthalmic Solution, 15 mL
  • Flurbiprofen Sodium 0.04% Ophthalmic Solution, 10 mL
  • Idoxuridine 0.1% Ophthalmic Solution, 15 mL
  • Megestrol Acetate 0.5% Ophthalmic Suspension, 10 mL
  • Pilocarpine HCL 0.1% Ophthalmic Solution, 10 mL
  • Prednisolone Acetate 1.5% Ophthalmic Suspension, 10 mL
  • Tacrolimus AQ 0.02%, 0.03%, 0.1%, 0.5% and 1% Ophthalmic Suspension, 10 mL
  • Tacrolimus AQ 0.02% and 0.03% Ophthalmic Suspension, 15 mL
  • Tacrolimus Corn Oil 0.02% and 0.03% Ophthalmic Solution, 10 mL
  • Tacrolimus Corn Oil 0.02% and 0.03% Ophthalmic Solution, 15 mL
  • Tacrolimus MCT 0.3%, 0.5% and 1% Ophthalmic Solution, 10 mL
  • Tacrolimus MCT 0.02% and 0.03% Ophthalmic Solution, 15 mL

503B Compounded Medications

Our portfolio is the largest among currently registered 503B outsourcing facilities in veterinary medicine. Browse the other formulations we manufacture.

Epicur-eyedrops

Ready to order?

Available for dispensing and unlimited hospital administration in all 50 states.*

*Varies based on individual state law. Federal law allows dispensing and administration – FDA Federal SEC. 503B. [21 U.S.C. 353b]